Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults (Q33936089)

30 July 2017

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults (English)

1 reference

30 July 2017

11

Todd Hulgan

1 reference

30 July 2017

3

David W Haas

1 reference

30 July 2017

2

Ayumi Shintani

1 reference

30 July 2017

Leigh Anne Redhage

1

1 reference

30 July 2017

Nkiruka Emeagwali

4

1 reference

30 July 2017

Milica Markovic

5

1 reference

30 July 2017

Ikwo Oboho

6

1 reference

30 July 2017

Christopher Mwenya

7

1 reference

30 July 2017

Husamettin Erdem

8

1 reference

30 July 2017

Edward P Acosta

9

1 reference

30 July 2017

Jason D Morrow

10

1 reference

30 July 2017

1 May 2009

1 reference

30 July 2017

1 reference

30 July 2017

10

1 reference

30 July 2017

181-192

1 reference

30 July 2017

3

1 reference

Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

The survival benefits of AIDS treatment in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Mitochondrial injury in the pathogenesis of antiretroviral-induced hepatic steatosis and lactic acidemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Oxidative stress in viral hepatitis and AIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Impact of nevirapine on lipid metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

The isoprostanes: unique bioactive products of lipid peroxidation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).

5 July 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Lipid Oxidative Markers Are Significantly Increased in Lipoatrophy But Not in Sustained Asymptomatic Hyperlactatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Oxidant stress is increased during treatment of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Factors associated with oxidative stress in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Greater oxidative stress in healthy young men compared with premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

A Comparison of the Effects of Nevirapine and Nelfinavir on Metabolism and Body Habitus in Antiretroviral-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Metabolic and Skeletal Complications of HIV Infection

29 October 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1003-181

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891063

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

29 October 2018

1 reference

12 December 2020

Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection

1 reference

12 December 2020

Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress

1 reference

12 December 2020

HIV-associated dementia, mitochondrial dysfunction, and oxidative stress

1 reference

12 December 2020

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

1 reference

12 December 2020

Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study

1 reference

12 December 2020

Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study

1 reference

12 December 2020

Identifiers

DOI

10.1310/HCT1003-181

1 reference

30 July 2017

1 reference

30 July 2017

1 reference